Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00846573 · ClinicalTrials.gov registry record · NA
Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders
A NA study, sponsored by University of Massachusetts, Worcester.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00846573 is a NA study that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 14 participants.
The verdict
NCT00846573, a NA study, was terminated before completion, sponsored by University of Massachusetts, Worcester.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of Hyperpolarized Helium-3 gas in MR imaging in COPD, asthmatics, CF and healthy volunteers.
Interventions
- DRUG Hyperpolarized Helium-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00846573
The ClinicalTrials.gov registry entry for NCT00846573 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperpolarized Helium-3 is the first listed.
NCT00846573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00846573 about?
NCT00846573 is a clinical study titled "Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders". The purpose of this study is to test the efficacy of Hyperpolarized Helium-3 gas in MR imaging in COPD, asthmatics, CF and healthy volunteers.
What is the current status of trial NCT00846573?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2008-11. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00846573?
The interventions under investigation include: Hyperpolarized Helium-3 (DRUG).
Who is sponsoring clinical trial NCT00846573?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.